News on capital raises, mergers and acquisitions, private equity, and grant funding across Dallas-Fort Worth. From early-stage funding to public exits, here’s a look at deals making business news in the region.
In a deal valued at $70 million, Dallas-based Trinity Industries Inc. has acquired RSI Logistics, a data-centric provider of proprietary software, logistics services, and terminal management solutions to the North American rail industry.
“We are excited about the acquisition of RSI Logistics. It is another step as we seek to expand our service offerings with complementary solutions that make rail a more compelling mode of transportation....
THE RIM scratch craft eats has locations in Fort Worth and Burleson. [Photo: Xperience Restaurant Group]
Elevate Credit Inc., a Fort Worth-based tech-enabled provider of innovative and responsible online credit solutions for non-prime consumers, has been acquired in a deal valued at $67 million by Dallas-based Park Cities Asset Management LLC, an alternative asset manager focused on providing flexible capital solutions.
“Elevate is pleased to join Park Cities as we embark on an exciting new chapter, one that will allow us to better serve our customers and drive innovation within our business,” Elevate CEO Jason Harvison said in a statement....
Dallas-based private investment firm Highlander Partners has acquired Black Sage Technologies, a provider of drone defense systems and technologies, from Acorn Growth Companies, a private equity firm exclusively investing in aerospace, defense, intelligence, and space....
Middle Market private equity firm Pharos Capital Group has sold its majority stake in portfolio company MOTION PT Group to Confluent Health.
Pharos is headquartered in Dallas and Nashville. No financial details were disclosed.
MOTION is a physical therapy, occupational therapy, and speech therapy company with 59 clinic locations across Connecticut, Maryland, Massachusetts, and New York....
Dallas-based Financial Strategies Acquisition Corp. has acquired Texas-based preclinical pharmaceutical company Austin Biosciences Corp.
Financial Strategies is a special purpose acquisition company led by CEO Alexander V. Schinzing. It said that upon the deal’s closing, Austin Biosciences will become a wholly owned subsidiary of the company.
Earlier this month, Financial Strategies announced that its board approved an extension of the period of time available to consummate the deal by one month from Feb....